Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ETAreceptor antagonist

Autor: Tilton, Ronald G., Munsch, Christy L., Sherwood, Sidney J., Chen, Shi-Juan, Chen, Yiu-Fai, Wu, Chengda, Block, Natalie, Dixon, Richard A.F., Brock, Tommy A.
Zdroj: In Pulmonary Pharmacology & Therapeutics April 2000 13(2):87-97
Databáze: ScienceDirect